Arkane Studios president Raphael Colantonio stepping down

After 18 years with the studio he helped found, Raphael Colantonio is departing Arkane to spend time with his family.

Longtime game developer and Arkane Studios president Raphael Colantonio is parting ways with the studio he founded nearly two decades ago. In a letter shared to Bethesda’s website, Colantonio announced his impending departure and detailed his next steps.

“The last 18 years have been an amazing adventure - from starting Arkane in 1999, to making our first game, Arx Fatalis, to joining ZeniMax Media in 2010 and releasing the Dishonored series and Prey to critical acclaim,” said Colantonio. “It is time for me to step out to spend some time with my son and reflect on what is important to me and my future.”

Colantonio was a key founding member of Arkane and has been with the developer since it first opened its doors 18 years back. In addition to being the studio's president, Colantonio has served as the creative director on a number of Arkane games, including the developer's most recent release, Prey.

Going forward, Arkane co-founder Harvey Smith will oversee the studio’s Austin offices while Colantonio notes that he himself will remain on board “as long as necessary” to ease the Lyon-based arm of the studio to its new management team.

Latest Jobs

Pocketwatch Games

Senior Gameplay Engineer


Cambridge, Massachusetts
Jr. Programmer

Gameloft Australia

Brisbane, Australia
Creative Director

Sucker Punch Productions

Bellevue, Washington
Senior Systems Designer
More Jobs   


Register for a
Subscribe to
Follow us

Game Developer Account

Game Developer Newsletter


Register for a

Game Developer Account

Gain full access to resources (events, white paper, webinars, reports, etc)
Single sign-on to all Informa products

Subscribe to

Game Developer Newsletter

Get daily Game Developer top stories every morning straight into your inbox

Follow us


Follow us @gamedevdotcom to stay up-to-date with the latest news & insider information about events & more